Bio-Rad Laboratories (BIO) Return on Capital Employed (2010 - 2026)
Bio-Rad Laboratories (BIO) reported Return on Capital Employed of 0.62% for Q1 2026, down 511.0% year-over-year from 0.15% in Q1 2025, and up 26.69% quarter-over-quarter from 0.49% in Q4 2025.
Bio-Rad Laboratories (BIO) Return on Capital Employed (2010 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has 17 years of Return on Capital Employed data on file, last reported at 0.62% in Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 0.62%, down 511.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.62% (down 511.0% YoY), and the FY2025 annual result was 0.5%, down 588.0% from the prior year.
- Return on Capital Employed rose to 0.62% in Q1 2026 per BIO's latest filing, from 0.49% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 8.84% in Q4 2022 and troughed at 100.1% in Q1 2024.
- A 5-year average of 3.0% and a median of 4.15% in 2022 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2024 and 2025: Return on Capital Employed sank 10648 bps in 2024, then jumped 10583 bps in 2025.
- A 5-year view of Return on Capital Employed shows it stood at 8.84% in 2022, then fell by 30 bps to 6.23% in 2023, then plunged by 1708 bps to 100.1% in 2024, then jumped by 100 bps to 0.49% in 2025, then gained by 27 bps to 0.62% in 2026.
- Business Quant data shows BIO's Return on Capital Employed at 0.62% in Q1 2026, 0.49% in Q4 2025, and 2.38% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 11.57% |
| 10 | Bio-Rad Laboratories | 7.62 Bn | 6.05 Bn | 309.40 Mn | 0.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.62% |
| Dec 31, 2025 | 0.49% |
| Sep 30, 2025 | 2.38% |
| Jun 30, 2025 | 4.75% |
| Mar 31, 2025 | 5.73% |
| Mar 31, 2024 | -100.10% |
| Dec 31, 2023 | 6.23% |
| Sep 30, 2023 | 3.17% |
| Jun 30, 2023 | 2.98% |
| Mar 31, 2023 | 6.38% |
| Dec 31, 2022 | 8.84% |
| Sep 30, 2022 | 4.08% |
| Jun 30, 2022 | 4.21% |
| Mar 31, 2022 | 8.22% |
| Dec 31, 2021 | 5.32% |
| Sep 30, 2021 | 3.36% |
| Jun 30, 2021 | 3.74% |
| Mar 31, 2021 | 6.83% |
| Dec 31, 2020 | 7.55% |
| Sep 30, 2020 | 2.93% |